Detecting significant heart murmurs using AI technology
EKO SENSORA: Detecting Clinically Significant Murmurs
This study is testing whether an AI-powered stethoscope can help doctors find important heart murmurs in patients with symptoms like chest pain or shortness of breath in the emergency room.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Corewell Health South Academic / other |
| Locations | 1 site (Saint Joseph, Michigan) |
| Trial ID | NCT06155643 on ClinicalTrials.gov |
What this trial studies
The Eko SENSORA project aims to evaluate the effectiveness of an AI-powered digital stethoscope in detecting clinically significant heart murmurs in patients presenting with symptoms such as chest pain, shortness of breath, or syncope in an emergency department setting. The device records heart sounds and utilizes machine learning algorithms to identify abnormalities that may indicate valvular heart disease. This early-phase intervention seeks to improve diagnostic accuracy and patient outcomes in emergency care.
Who should consider this trial
Good fit: Ideal candidates include adults presenting with chest pain, shortness of breath, or syncope, particularly those over 50 with a history of cardiovascular risk factors.
Not a fit: Patients under 18 years old or those in contact isolation may not benefit from this study.
Why it matters
Potential benefit: If successful, this technology could enhance the early detection of serious cardiac conditions, leading to timely and potentially life-saving interventions.
How similar studies have performed: Other studies utilizing AI for heart sound analysis have shown promise, suggesting potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Chief complaint of chest pain, shortness of breath, difficulty breathing, or syncope/near-syncope. * Patients with chief complaint of Weakness would be eligible if over the age of 50 and have a history of at least two of hypertension, BMI\>/= 30, diabetes, hyperlipidemia, atrial fibrillation, heart attack, stroke/Transient ischemic attack, prior cardiac surgery or angiography Exclusion Criteria: * Contact isolation patients * Pediatric patients under the age of 18
Where this trial is running
Saint Joseph, Michigan
- Corewell Health Lakeland — Saint Joseph, Michigan, United States (Recruiting)
Study contacts
- Study coordinator: Monique Luna, MS
- Email: monique.allen@corewellhealth.org
- Phone: 2699838679
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.